Driehaus Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.1M Buy
+1,585,880
New +$11M 0.08% 270
2021
Q4
– Sell
-461,574
Closed -$22.7M – 422
2021
Q3
$22.7M Buy
461,574
+103,167
+29% +$5.03M 0.27% 119
2021
Q2
$15M Buy
358,407
+67,721
+23% +$2.62M 0.2% 161
2021
Q1
$10.4M Buy
290,686
+66,387
+30% +$2.2M 0.15% 198
2020
Q4
$6.29M Buy
+224,299
New +$6.25M 0.1% 228

Other funds holding MRVI

Driehaus Capital Management's MRVI Position: Q3 2026 in Review

Driehaus Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 1,585,880 shares worth $12.1M. The stake represents 0.08% of the portfolio and ranks #270 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in MRVI as recently as Q3 2021.

Driehaus Capital Management first reported a position in MRVI in Q4 2020 and has held it in 5 quarters since. The position peaked at $22.7M in Q3 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Driehaus Capital Management held 1,585,880 shares of Maravai LifeSciences worth $12.1M as of Q3 2026.
  • Maravai LifeSciences was a new Driehaus Capital Management position in Q3 2026.
  • Maravai LifeSciences made up 0.08% of Driehaus Capital Management's portfolio in Q3 2026, its #270 holding.
  • Driehaus Capital Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 5 quarters since.
  • Driehaus Capital Management's Maravai LifeSciences position peaked at $22.7M in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.